
Insulet (PODD) Stock Forecast & Price Target
Insulet (PODD) Analyst Ratings
Bulls say
Insulet is a strong performer in the healthcare industry, with a track record of strong earnings and growth. Its innovative Omnipod system provides a competitive advantage in the market and has a large user base, making it a solid investment. However, its stock price may be volatile due to market conditions and potential competition, so careful monitoring is advised.
Bears say
Insulet is facing a deceleration in growth due to conservatism in their guidance, tougher year-over-year comparisons, and potential softness in the market related to insurance deductible resets and ACA subsidy expirations. Despite these challenges, the company remains confident in its long-term growth potential and has several growth drivers in place such as the Omnipod 5 AID system and expanded T2D patient population. However, there is a risk of slower adoption of T2D patients and potential competition in the market.
This aggregate rating is based on analysts' research of Insulet and is not a guaranteed prediction by Public.com or investment advice.
Insulet (PODD) Analyst Forecast & Price Prediction
Start investing in Insulet (PODD)
Order type
Buy in
Order amount
Est. shares
0 shares